Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes

Shin‐ichiro Imai(Washington University in St. Louis)
Frontiers in bioscience
January 1, 2009
10.2741/3428
Cited by 75

Related Papers

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
|Nature|2000|3.5k
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
|Cell|2001|2.7k
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
|Cell|2001|2.1k
NAD+ and sirtuins in aging and disease
|Trends in Cell Biology|2014|1.4k
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
|Cell Metabolism|2011|1.3k